A 62-year-old with nonsevere CDI has high risk for recurrence (age65, CKD). What adjunct reduces recurrence when added to standard-of-care antibiotic...

Question

A 62-year-old with nonsevere CDI has high risk for recurrence (age>65, CKD). What adjunct reduces recurrence when added to standard-of-care antibiotics?

Accepted Answer

Bezlotoxumab single IV dose

Answer

Probiotics daily

Answer

Cholestyramine

Answer

Metronidazole IV

Answer

No adjunctive therapy is recommended

us-usmle-step-2 MCQ (SBA): C. difficile Recurrence Prevention

A 62-year-old with nonsevere CDI has high risk for recurrence (age>65, CKD). What adjunct reduces recurrence when added to standard-of-care antibiotics?